National Institute of Genomic Medicine

National Institute of Genomic Medicine

The National Institute of Genomic Medicine is one of Mexico's twelve national institutes under the Secretariat of Health. The institute was founded in 2004, with its official headquarters built eight years later. INMEGEN is dedicated to the development of genomic medicine for the Mexican population. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for National Institute of Genomic Medicine, Mexico, covering academic research published from 2000 to 2022. Read More.


Open Access Percentage

67%


Total
Publications

1.6K


Total Open
Publications

1K


Total
Citations

40K


Open Access
Percentage

67%


Total
Publications

1.6K


Total Open
Publications

1K


Total
Citations

40K

Wikipedia

Website

download

Breakdown

9% 48% 10% 33%

Publisher Open

9%

Both

48%

Other Platform Open

10%

Closed

33%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
20002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

020406080100120140160180200220240Total Publications
20002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022

Open

Closed

Publisher Open

69%OA Journal

OA Journal 69%

618

Hybrid 19%

176

No Guarantees 12%

105

Other Platform Open

Domain 85%

770

Institution 18%

167

Public 13%

120

Other Internet 12%

109

Preprint 12%

108

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
770
Europe PMC
Domain
438
Semantic Scholar
Public
111
DOI
Other Internet
55
bioRxiv
Preprint
52
Research Square
Preprint
29
University College London - UCL Discovery
Institution
24
California Digital Library - eScholarship
Other Internet
24
Red Federada de Repositorios Institucionales de Publicaciones Científicas - LA Referencia
Other Internet
23
Unknown Repository
Other Internet
21
1 / 17

Data updated 3 October 2023

Share

Share

Share